Clorox (CLX)
Market Price (7/13/2026): $96.52 | Market Cap: $11.7 BilInvestor Relations Sector: Consumer Staples | Industry: Household Products
Clorox (CLX)
Market Price (7/13/2026): $96.52Market Cap: $11.7 BilSector: Consumer StaplesIndustry: Household Products
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.0%, Dividend Yield is 2.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.8% Low stock price volatilityVol 12M is 29% Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more. | Weak multi-year price returns2Y Excs Rtn is -58%, 3Y Excs Rtn is -103% | Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.7%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.9% Key risksCLX key risks include [1] significant operational disruption and financial impact from its major ERP system transition and [2] widespread business interruption stemming from a recent cyberattack. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 9.0%, Dividend Yield is 2.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 4.8% |
| Low stock price volatilityVol 12M is 29% |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -58%, 3Y Excs Rtn is -103% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.7%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.9% |
| Key risksCLX key risks include [1] significant operational disruption and financial impact from its major ERP system transition and [2] widespread business interruption stemming from a recent cyberattack. |
Qualitative Assessment
AI Analysis | Feedback
Clorox (CLX) stock has lost about 5% since 3/31/2026 because of the following key factors:
1. Clorox significantly lowered its financial outlook for fiscal year 2026, which ends on June 30, 2026. This updated guidance, announced with its third-quarter fiscal year 2026 results on April 30, 2026, projected net sales to decline by approximately 6% and organic sales to decrease by around 9%, both worse than previous expectations. The company also dramatically reduced its diluted EPS forecast for fiscal year 2026 to between $4.78 and $4.98, representing a 24% to 27% year-over-year decrease.
2. The revised fiscal year 2026 outlook was largely driven by an anticipated inventory drawdown by retailers. This temporary effect stems from retailers having built up inventory in advance of Clorox's enterprise resource planning (ERP) system transition in fiscal year 2025, and now drawing down on that stock, which is expected to reduce fiscal year 2026 earnings per share by about $0.90.
Show more
Clorox (CLX) stock has lost about 5% since 3/31/2026 because of the following key factors:
1. Clorox significantly lowered its financial outlook for fiscal year 2026, which ends on June 30, 2026. This updated guidance, announced with its third-quarter fiscal year 2026 results on April 30, 2026, projected net sales to decline by approximately 6% and organic sales to decrease by around 9%, both worse than previous expectations. The company also dramatically reduced its diluted EPS forecast for fiscal year 2026 to between $4.78 and $4.98, representing a 24% to 27% year-over-year decrease.
2. The revised fiscal year 2026 outlook was largely driven by an anticipated inventory drawdown by retailers. This temporary effect stems from retailers having built up inventory in advance of Clorox's enterprise resource planning (ERP) system transition in fiscal year 2025, and now drawing down on that stock, which is expected to reduce fiscal year 2026 earnings per share by about $0.90.
3. Persistent gross margin pressures continued to weigh on profitability. For the third quarter of fiscal year 2026, gross margin decreased by 140 basis points to 43.2%, primarily due to higher manufacturing and logistics costs and an unfavorable mix. The full fiscal year 2026 gross margin is now expected to be down 250 to 300 basis points, a more significant decline than previously forecast.
4. The announcement of a CEO leadership transition created investor uncertainty. In early June 2026, Clorox disclosed that Chair and CEO Linda Rendle requested the board initiate a search for her successor due to health reasons, though she would remain CEO during the search and then move to an advisory role. This change introduces an element of leadership risk for the company.
Show less
Stock Movement Drivers
Fundamental Drivers
The -5.6% change in CLX stock from 3/31/2026 to 7/12/2026 was primarily driven by a -6.0% change in the company's P/E Multiple.| (LTM values as of) | 3312026 | 7122026 | Change |
|---|---|---|---|
| Stock Price ($) | 102.34 | 96.56 | -5.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 6,758 | 6,760 | 0.0% |
| Net Income Margin (%) | 11.2% | 11.2% | 0.1% |
| P/E Multiple | 16.5 | 15.5 | -6.0% |
| Shares Outstanding (Mil) | 122 | 121 | 0.2% |
| Cumulative Contribution | -5.6% |
Market Drivers
3/31/2026 to 7/12/2026| Return | Correlation | |
|---|---|---|
| CLX | -5.6% | |
| Market (SPY) | 16.1% | -0.4% |
| Sector (XLP) | 2.6% | 55.3% |
Fundamental Drivers
The -2.0% change in CLX stock from 12/31/2025 to 7/12/2026 was primarily driven by a -4.3% change in the company's Net Income Margin (%).| (LTM values as of) | 12312025 | 7122026 | Change |
|---|---|---|---|
| Stock Price ($) | 98.48 | 96.56 | -2.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 6,771 | 6,760 | -0.2% |
| Net Income Margin (%) | 11.7% | 11.2% | -4.3% |
| P/E Multiple | 15.3 | 15.5 | 1.5% |
| Shares Outstanding (Mil) | 123 | 121 | 1.0% |
| Cumulative Contribution | -2.0% |
Market Drivers
12/31/2025 to 7/12/2026| Return | Correlation | |
|---|---|---|
| CLX | -2.0% | |
| Market (SPY) | 11.0% | 7.8% |
| Sector (XLP) | 8.9% | 60.7% |
Fundamental Drivers
The -16.0% change in CLX stock from 6/30/2025 to 7/12/2026 was primarily driven by a -24.1% change in the company's P/E Multiple.| (LTM values as of) | 6302025 | 7122026 | Change |
|---|---|---|---|
| Stock Price ($) | 114.89 | 96.56 | -16.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,019 | 6,760 | -3.7% |
| Net Income Margin (%) | 9.9% | 11.2% | 13.1% |
| P/E Multiple | 20.4 | 15.5 | -24.1% |
| Shares Outstanding (Mil) | 123 | 121 | 1.7% |
| Cumulative Contribution | -16.0% |
Market Drivers
6/30/2025 to 7/12/2026| Return | Correlation | |
|---|---|---|
| CLX | -16.0% | |
| Market (SPY) | 23.2% | 6.8% |
| Sector (XLP) | 6.0% | 59.8% |
Fundamental Drivers
The -32.2% change in CLX stock from 6/30/2023 to 7/12/2026 was primarily driven by a -93.5% change in the company's P/E Multiple.| (LTM values as of) | 6302023 | 7122026 | Change |
|---|---|---|---|
| Stock Price ($) | 142.39 | 96.56 | -32.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 7,171 | 6,760 | -5.7% |
| Net Income Margin (%) | 1.0% | 11.2% | 983.7% |
| P/E Multiple | 237.9 | 15.5 | -93.5% |
| Shares Outstanding (Mil) | 124 | 121 | 1.9% |
| Cumulative Contribution | -32.2% |
Market Drivers
6/30/2023 to 7/12/2026| Return | Correlation | |
|---|---|---|
| CLX | -32.2% | |
| Market (SPY) | 76.3% | 14.0% |
| Sector (XLP) | 22.2% | 57.4% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CLX Return | -11% | -17% | 5% | 18% | -36% | -5% | -45% |
| Peers Return | 12% | -14% | 11% | 15% | -10% | 10% | 23% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 101% |
Monthly Win Rates [3] | |||||||
| CLX Win Rate | 42% | 50% | 58% | 50% | 17% | 43% | |
| Peers Win Rate | 53% | 38% | 52% | 63% | 35% | 60% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 57% | |
Max Drawdowns [4] | |||||||
| CLX Max Drawdown | -28% | -33% | -33% | -18% | -38% | -31% | |
| Peers Max Drawdown | -11% | -28% | -15% | -11% | -23% | -16% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PG, CL, KMB, CHD, ECL. See CLX Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/10/2026 (YTD)
How Low Can It Go
| Event | CLX | S&P 500 |
|---|---|---|
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -23.3% | -9.5% |
| % Gain to Breakeven | 30.3% | 10.5% |
| Time to Breakeven | 93 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -28.9% | -24.5% |
| % Gain to Breakeven | 40.7% | 32.4% |
| Time to Breakeven | 319 days | 427 days |
| 2016-2017 Trump Reflation Bond Selloff | ||
| % Loss | -10.3% | -3.7% |
| % Gain to Breakeven | 11.5% | 3.9% |
| Time to Breakeven | 85 days | 6 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -13.2% | -17.9% |
| % Gain to Breakeven | 15.2% | 21.8% |
| Time to Breakeven | 299 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -27.9% | -53.4% |
| % Gain to Breakeven | 38.7% | 114.4% |
| Time to Breakeven | 277 days | 1085 days |
In The Past
Clorox's stock fell -2.2% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 2.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | CLX | S&P 500 |
|---|---|---|
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -23.3% | -9.5% |
| % Gain to Breakeven | 30.3% | 10.5% |
| Time to Breakeven | 93 days | 24 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -28.9% | -24.5% |
| % Gain to Breakeven | 40.7% | 32.4% |
| Time to Breakeven | 319 days | 427 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -27.9% | -53.4% |
| % Gain to Breakeven | 38.7% | 114.4% |
| Time to Breakeven | 277 days | 1085 days |
In The Past
Clorox's stock fell -2.2% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 2.2% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Clorox (CLX)
The Clorox Company (CLX) is a global manufacturer and marketer of a wide array of consumer and professional products. Established in 1913, the company operates across four main segments: Health and Wellness, Household, Lifestyle, and International, providing essential solutions for everyday living and specialized needs worldwide.
Clorox's extensive product portfolio encompasses many well-known brands. Its Health and Wellness segment offers cleaning and disinfecting products like Clorox, Pine-Sol, and Formula 409, along with professional cleaning solutions under CloroxPro, and vitamins, minerals, and supplements through brands such as RenewLife and Rainbow Light. The Household segment includes popular items like Fresh Step cat litter, Glad bags and wraps, and Kingsford grilling products. Additionally, the Lifestyle segment features Hidden Valley dressings, Burt's Bees natural personal care, and Brita water-filtration systems. Many of these brands are also sold internationally.
The company primarily serves individual consumers globally, distributing its products through a broad network including mass retailers, grocery outlets, warehouse clubs, dollar stores, and various e-commerce channels. Beyond the consumer market, Clorox also caters to professional clients in healthcare and food service with specialized cleaning, disinfecting, and food service products.
AI Analysis | Feedback
Clorox is like a smaller, more focused Procter & Gamble (P&G), specializing in a wide range of household and personal care essentials.
Think of Clorox as a diversified consumer goods company similar to Procter & Gamble (P&G), but also known for unique brands like Burt's Bees, Hidden Valley, and Kingsford.
AI Analysis | Feedback
- Cleaning & Disinfecting Products: This category includes laundry additives, home care products, and professional cleaning and disinfecting solutions.
- Vitamins, Minerals, & Supplements: Clorox offers a range of health and wellness products, including vitamins, minerals, and dietary supplements.
- Cat Litter: The company provides various cat litter products under multiple brand names for pet care.
- Bags & Wraps: This segment includes bags for waste disposal and food storage, along with plastic wraps.
- Grilling Products: Clorox manufactures and markets charcoal and related grilling accessories.
- Food Products (Dressings, Dips, Sauces): Consumer-focused food items such as salad dressings, dips, seasonings, and sauces are offered.
- Natural Personal Care Products: This category includes a variety of personal care items made with natural ingredients.
- Water Filtration Systems: Clorox provides water-filtration systems and replacement filters for home use.
AI Analysis | Feedback
Major Customers of The Clorox Company (CLX)
The Clorox Company primarily sells its products to other companies, specifically major retailers and distributors, who then sell these products to individual consumers. Based on the distribution channels described, its major customers include:
- Walmart Inc. (WMT)
- Amazon.com, Inc. (AMZN)
- The Kroger Co. (KR)
- Target Corporation (TGT)
- Costco Wholesale Corporation (COST)
AI Analysis | Feedback
AI Analysis | Feedback
Linda Rendle, Chair and CEO
Linda Rendle is the chair and CEO of The Clorox Company, a role she assumed as CEO in September 2020 and as chair in January 2024. She has been with Clorox for over 20 years, having held numerous senior leadership positions including president, executive vice president – Cleaning, International, Strategy and Operations, and vice president and general manager – Home Care. Rendle began her career in sales management at The Procter & Gamble Company.
Luc Bellet, Executive Vice President and Chief Financial Officer
Luc Bellet is the executive vice president and chief financial officer of The Clorox Company, a position he assumed effective April 1, 2025. With nearly 20 years at Clorox, he has held various financial and operational leadership roles, including treasurer and head of real estate and investor relations, and leading internal audit and financial planning and analysis. Before joining Clorox, Bellet held finance, business, and operations positions at Nestlé and Danone, and was involved in creating and growing the startup Galaxy Inc.
Kirsten Marriner, Executive Vice President and Chief Administrative Officer
Kirsten Marriner joined Clorox in March 2016 as senior vice president – chief people officer, and was named executive vice president – chief people officer in January 2019. She became executive vice president and chief administrative officer in March 2025. With over 30 years of experience in human resources, her career includes serving as senior vice president and chief human resources officer at Omnicare (which was acquired by CVS Health Corporation), and holding leadership roles at Fifth Third Bank and KeyCorp. She also worked in HR consulting at Deloitte and KPMG.
Nina Barton, Executive Vice President and Group President – Care & Connection
Nina Barton assumed the role of executive vice president and group president – Care & Connection at The Clorox Company in July 2024. Her career spans over 25 years in consumer packaged goods, during which she has a proven track record of building brands and growing businesses. Prior to Clorox, she served as CEO of Vytalogy Wellness (which includes brands like Natrol and Jarrow Formulas) and was the global chief growth officer at The Kraft Heinz Company. She also held positions of increasing responsibility at Johnson & Johnson, L'Oréal, and Procter & Gamble.
Chris Hyder, Executive Vice President and Group President – Health & Hygiene
Chris Hyder is the executive vice president and group president – Health & Hygiene at The Clorox Company, a position he assumed in October 2022. He oversees Clorox's U.S. Cleaning, Professional Products, and various international business units. Hyder began his career at Clorox in 2003 as an associate marketing manager and has since held various roles including vice president and general manager – Home Care, and general manager for Australia, New Zealand, and South Africa. Before joining Clorox, he worked as a brand manager at The Learning Company and a marketing assistant at General Mills.
AI Analysis | Feedback
The Clorox Company (CLX) faces several key risks that could impact its business operations and financial performance:
- Supply Chain and Cost Vulnerabilities: Clorox is susceptible to significant risks stemming from supply chain disruptions, rising costs of raw materials and transportation, and labor shortages. These vulnerabilities can lead to increased operating expenses, product shortages, and pressure on gross margins. The company's reliance on certain single-source suppliers further exacerbates these risks. Additionally, macroeconomic factors like inflation and tariffs have directly impacted costs and profitability. A notable example is the 2023 cyberattack on one of Clorox's suppliers, which caused significant operational disruptions and financial losses, highlighting the broad impact of supply chain security.
- Intense Competition and Changing Consumer Preferences: Clorox operates in highly competitive markets, challenged by both national brands and private labels. This competition often involves aggressive pricing strategies, marketing campaigns, and continuous innovation, which can erode Clorox's market share and profitability. Furthermore, changing consumer preferences, particularly a trend towards value-seeking during economic uncertainties and increased demand for eco-friendly products, can negatively impact sales and overall market share, as evidenced by recent sluggish consumption trends and consumers opting for cheaper alternatives.
- Enterprise Resource Planning (ERP) System Transition Impact: The company is undergoing a significant Enterprise Resource Planning (ERP) system transition in the U.S. This transition is identified as a material operational risk, posing a "significant, measurable drag" on the near-term fiscal year 2026 outlook. It has also led to temporary inventory builds and subsequent reversals, which can create operational complexities and impact financial results.
AI Analysis | Feedback
The accelerating consumer trend towards sustainable, eco-friendly, and zero-waste household products and personal care items poses a significant threat. This movement is fostering the growth of new direct-to-consumer and specialized brands offering refillable, concentrated, plant-based, and plastic-free alternatives for cleaning products, bags, wraps, and personal care. These alternatives directly challenge the traditional product formulations, packaging, and environmental impact of many of Clorox's long-standing, mass-market brands such as Clorox, Pine-Sol, Glad, and Kingsford, potentially leading to erosion of market share as consumer preferences shift.
AI Analysis | Feedback
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for The Clorox Company (CLX) over the next 2-3 years:
- Product Innovation and New Launches: Clorox is prioritizing and investing in a robust innovation pipeline across its major brands, particularly within its cleaning and household product categories. This focus on launching new products and category relaunches is expected to accelerate time-to-market and drive demand.
- Strategic Acquisitions: The planned acquisition of GOJO Industries, the maker of PURELL, is anticipated to significantly expand Clorox's presence and boost growth within its Health and Wellness segment, reinforcing its leadership in the health and hygiene sector.
- Strategic Pricing and Premiumization Initiatives: Clorox continues to proactively adjust its pricing strategies to navigate inflation and evolving consumer behaviors. The company employs a "dual pricing" approach, selectively adjusting prices and promotional support across its portfolio to balance affordability for consumers with sustained profitability and gross margin expansion. While the benefit from U.S. pricing may lessen as previous increases are lapped, international markets like Argentina are still seeing price increases.
- Recovery of Distribution and Market Share: Following disruptions from a cyberattack and an Enterprise Resource Planning (ERP) system transition, Clorox is actively focused on rebuilding retailer inventories, restoring distribution, and regaining market shares. This recovery effort is expected to drive volume and household penetration through strengthened demand creation plans.
- International Market Expansion: The International segment is demonstrating positive organic sales growth, driven by favorable price mix, foreign exchange rates, and increased volume. Continued strategic pricing actions in international markets, such as the double-digit price increases in Argentina, are expected to contribute to overall revenue growth.
AI Analysis | Feedback
Capital Allocation Decisions for Clorox (CLX)
Share Repurchases
- Clorox's annual share buybacks were reported as $332 million in 2025.
- The company's trailing twelve months (TTM) share buybacks as of September 2025 were -$354 million.
- Over the past five years, Clorox returned $3.2 billion to shareholders through dividends and buybacks.
Share Issuance
- Clorox's issuance of common stock averaged 33.6 million for fiscal years ending June 2021 to 2025.
- The issuance of common stock peaked at 103 million in June 2021.
- The issuance hit a 5-year low of 1 million in June 2024.
Capital Expenditures
- Clorox's capital expenditures averaged $248.4 million for fiscal years ending June 2021 to 2025.
- The company's latest twelve months capital expenditures are $206 million.
- Capital expenditure growth of 3.77% was primarily focused on investments in transformation and digitalization, as well as operational improvements and brand and innovation efforts.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Clorox Stock Slides 6.4% In A Single Day, Now Is Not The Time To Buy The Stock | 05/30/2026 | |
| Clorox Stock 6-Day Losing Spree: Stock Falls 8.0% | 03/25/2026 | |
| Clorox Earnings Notes | 12/29/2026 | |
| Is Wall Street Underestimating Clorox Stock's Potential? | 12/12/2025 | |
| 5-Day Rally Sends Clorox Stock Up 9.5% | 11/27/2025 | |
| Clorox Stock: High Cash Flow - Why Not Watch It? | 11/18/2025 | |
| Clorox Stock Drop Looks Sharp, But How Deep Can It Go? | 10/17/2025 | |
| ARTICLES | ||
| S&P 500 Movers | Winners: DELL, NTAP, NOW | Losers: CLX, RMD, INTC | 05/30/2026 | |
| Stocks Trading At 52-Week Low | 05/02/2026 | |
| S&P 500 Movers | Winners: CBOE, PSKY, SNDK | Losers: CLX, SYK, AMGN | 05/02/2026 | |
| Clorox Stock Plummets -8% With 6-Day Losing Streak | 03/25/2026 | |
| S&P 500 Stocks Trading At 52-Week Low | 12/23/2025 |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 104.48 |
| Mkt Cap | 55.7 |
| Rev LTM | 16,504 |
| Op Inc LTM | 2,725 |
| FCF LTM | 1,854 |
| FCF 3Y Avg | 2,045 |
| CFO LTM | 3,112 |
| CFO 3Y Avg | 3,018 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.8% |
| Rev Chg 3Y Avg | 3.2% |
| Rev Chg Q | 5.0% |
| QoQ Delta Rev Chg LTM | 1.2% |
| Op Inc Chg LTM | -3.0% |
| Op Inc Chg 3Y Avg | 4.6% |
| Op Mgn LTM | 17.7% |
| Op Mgn 3Y Avg | 17.3% |
| QoQ Delta Op Mgn LTM | 0.0% |
| CFO/Rev LTM | 19.4% |
| CFO/Rev 3Y Avg | 18.7% |
| FCF/Rev LTM | 14.3% |
| FCF/Rev 3Y Avg | 14.4% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 55.7 |
| P/S | 3.6 |
| P/Op Inc | 17.5 |
| P/EBIT | 18.8 |
| P/E | 25.8 |
| P/CFO | 18.3 |
| Total Yield | 5.1% |
| Dividend Yield | 1.9% |
| FCF Yield 3Y Avg | 4.0% |
| D/E | 0.1 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 1.4% |
| 3M Rtn | 1.7% |
| 6M Rtn | 9.1% |
| 12M Rtn | -2.1% |
| 3Y Rtn | 4.3% |
| 1M Excs Rtn | -0.9% |
| 3M Excs Rtn | -10.0% |
| 6M Excs Rtn | 2.4% |
| 12M Excs Rtn | -23.3% |
| 3Y Excs Rtn | -68.2% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Health and Wellness | 2,697 | 2,485 | 2,532 | 2,427 | 2,980 |
| Household | 2,001 | 1,950 | 2,098 | 1,984 | 1,981 |
| Lifestyle | 1,303 | 1,275 | 1,338 | 1,253 | 1,218 |
| International | 1,065 | 1,162 | 1,181 | 1,180 | 1,162 |
| Corporate and Other | 38 | 221 | 240 | 263 | |
| Total | 7,104 | 7,093 | 7,389 | 7,107 | 7,341 |
| $ Mil | 2005 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|
| U.S. Household Products and Canada | 633 | 607 | 599 | 470 | |
| U.S. Specialty Products | 435 | 521 | 403 | 466 | 1 |
| International | 119 | 84 | 0 | ||
| Latin America/Other Household Products | 66 | 68 | |||
| Household Products | 0 | ||||
| Total | 1,187 | 1,194 | 1,070 | 1,020 | 1 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| International | 1,329 | 1,327 | 1,410 | 1,453 | 1,489 |
| Health and Wellness | 1,217 | 1,124 | 1,184 | 1,275 | 2,043 |
| Lifestyle | 1,103 | 1,110 | 1,091 | 1,035 | 1,011 |
| Household | 1,091 | 1,088 | 1,082 | 1,045 | 912 |
| Corporate and Other | 821 | 1,102 | 1,178 | 1,350 | 879 |
| Total | 5,561 | 5,751 | 5,945 | 6,158 | 6,334 |
Price Behavior
| Market Price | $96.56 | |
| Market Cap ($ Bil) | 11.7 | |
| First Trading Date | 03/21/1983 | |
| Distance from 52W High | -23.2% | |
| 50 Days | 200 Days | |
| DMA Price | $93.71 | $104.48 |
| DMA Trend | down | down |
| Distance from DMA | 3.0% | -7.6% |
| 3M | 1YR | |
| Volatility | 39.7% | 29.3% |
| Downside Capture | -35.96 | 13.07 |
| Upside Capture | -49.62 | -16.66 |
| Correlation (SPY) | -8.9% | 6.3% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -0.82 | -0.48 | 0.03 | 0.18 | 0.15 | 0.23 |
| Up Beta | -0.67 | 1.41 | 1.30 | 1.03 | 0.88 | 0.46 |
| Down Beta | -1.28 | -0.70 | -1.13 | 0.15 | -0.01 | 0.07 |
| Up Capture | -34% | -75% | -28% | -10% | -9% | 1% |
| Bmk +ve Days | 11 | 24 | 40 | 67 | 140 | 429 |
| Stock +ve Days | 11 | 21 | 31 | 66 | 126 | 370 |
| Down Capture | -101% | -120% | -38% | -15% | 8% | 49% |
| Bmk -ve Days | 10 | 17 | 23 | 58 | 112 | 321 |
| Stock -ve Days | 10 | 20 | 32 | 59 | 125 | 379 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLX | |
|---|---|---|---|---|
| CLX | -20.0% | 29.2% | -0.76 | - |
| Sector ETF (XLP) | 6.3% | 13.5% | 0.20 | 60.0% |
| Equity (SPY) | 22.1% | 12.5% | 1.31 | 6.8% |
| Gold (GLD) | 23.5% | 27.8% | 0.75 | 9.3% |
| Commodities (DBC) | 23.6% | 18.7% | 0.99 | -20.0% |
| Real Estate (VNQ) | 13.4% | 13.9% | 0.67 | 42.2% |
| Bitcoin (BTCUSD) | -42.5% | 42.8% | -1.17 | -1.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLX | |
|---|---|---|---|---|
| CLX | -8.5% | 26.3% | -0.34 | - |
| Sector ETF (XLP) | 6.5% | 13.4% | 0.26 | 55.7% |
| Equity (SPY) | 13.4% | 17.1% | 0.61 | 18.4% |
| Gold (GLD) | 17.8% | 18.3% | 0.79 | 2.6% |
| Commodities (DBC) | 7.3% | 19.5% | 0.27 | -11.6% |
| Real Estate (VNQ) | 2.9% | 18.9% | 0.05 | 30.0% |
| Bitcoin (BTCUSD) | 13.8% | 53.4% | 0.44 | 3.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CLX | |
|---|---|---|---|---|
| CLX | -0.4% | 24.7% | -0.01 | - |
| Sector ETF (XLP) | 7.3% | 14.8% | 0.36 | 54.4% |
| Equity (SPY) | 15.6% | 17.9% | 0.75 | 21.8% |
| Gold (GLD) | 11.6% | 16.1% | 0.59 | 5.9% |
| Commodities (DBC) | 6.0% | 18.0% | 0.26 | -5.9% |
| Real Estate (VNQ) | 5.1% | 20.7% | 0.21 | 28.0% |
| Bitcoin (BTCUSD) | 58.6% | 66.2% | 0.99 | 2.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 4/30/2026 | -9.7% | -4.5% | -7.6% |
| 2/3/2026 | 2.4% | 5.6% | -1.1% |
| 11/3/2025 | 1.2% | -4.1% | -3.7% |
| 7/31/2025 | -2.0% | 0.4% | -4.9% |
| 5/5/2025 | -2.4% | -0.2% | -6.3% |
| 2/3/2025 | -7.2% | -7.9% | -6.3% |
| 10/30/2024 | 1.3% | 4.0% | 6.8% |
| 8/1/2024 | 7.4% | 7.6% | 19.0% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 12 | 14 | 9 |
| # Negative | 12 | 10 | 15 |
| Median Positive | 4.5% | 4.9% | 3.4% |
| Median Negative | -5.9% | -4.5% | -5.5% |
| Max Positive | 9.8% | 14.3% | 24.7% |
| Max Negative | -14.5% | -14.5% | -12.7% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 4/30/2026 | -9.7% | -4.5% | -7.6% |
| 2/3/2026 | 2.4% | 5.6% | -1.1% |
| 11/3/2025 | 1.2% | -4.1% | -3.7% |
| 7/31/2025 | -2.0% | 0.4% | -4.9% |
| 5/5/2025 | -2.4% | -0.2% | -6.3% |
| 2/3/2025 | -7.2% | -7.9% | -6.3% |
| 10/30/2024 | 1.3% | 4.0% | 6.8% |
| 8/1/2024 | 7.4% | 7.6% | 19.0% |
| 4/30/2024 | -5.6% | -4.5% | -12.7% |
| 2/1/2024 | 5.6% | 4.2% | 2.0% |
| 11/1/2023 | 6.6% | 14.3% | 24.7% |
| 8/2/2023 | 9.0% | 7.6% | 3.4% |
| 5/2/2023 | 4.7% | 0.2% | -5.4% |
| 2/2/2023 | 9.8% | 6.4% | 7.8% |
| 11/1/2022 | -6.1% | -2.5% | 2.2% |
| 8/3/2022 | -4.7% | 0.4% | 0.9% |
| 5/2/2022 | 3.0% | 9.9% | -1.8% |
| 2/3/2022 | -14.5% | -14.5% | -12.0% |
| 11/1/2021 | 1.2% | 0.5% | 1.4% |
| 8/3/2021 | -9.5% | -9.0% | -7.3% |
| 4/30/2021 | -1.9% | -0.7% | -5.0% |
| 2/4/2021 | -6.3% | -8.8% | -9.9% |
| 11/2/2020 | 4.2% | 5.8% | -1.4% |
| 8/3/2020 | -1.9% | 0.4% | -5.5% |
| SUMMARY STATS | |||
| # Positive | 12 | 14 | 9 |
| # Negative | 12 | 10 | 15 |
| Median Positive | 4.5% | 4.9% | 3.4% |
| Median Negative | -5.9% | -4.5% | -5.5% |
| Max Positive | 9.8% | 14.3% | 24.7% |
| Max Negative | -14.5% | -14.5% | -12.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 04/30/2026 | 10-Q |
| 12/31/2025 | 02/03/2026 | 10-Q |
| 09/30/2025 | 11/03/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-K |
| 03/31/2025 | 05/05/2025 | 10-Q |
| 12/31/2024 | 02/03/2025 | 10-Q |
| 09/30/2024 | 10/30/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-K |
| 03/31/2024 | 04/30/2024 | 10-Q |
| 12/31/2023 | 02/01/2024 | 10-Q |
| 09/30/2023 | 11/01/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-K |
| 03/31/2023 | 05/02/2023 | 10-Q |
| 12/31/2022 | 02/02/2023 | 10-Q |
| 09/30/2022 | 11/01/2022 | 10-Q |
| 06/30/2022 | 08/10/2022 | 10-K |
| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 04/30/2026 | 10-Q |
| 12/31/2025 | 02/03/2026 | 10-Q |
| 09/30/2025 | 11/03/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-K |
| 03/31/2025 | 05/05/2025 | 10-Q |
| 12/31/2024 | 02/03/2025 | 10-Q |
| 09/30/2024 | 10/30/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-K |
| 03/31/2024 | 04/30/2024 | 10-Q |
| 12/31/2023 | 02/01/2024 | 10-Q |
| 09/30/2023 | 11/01/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-K |
| 03/31/2023 | 05/02/2023 | 10-Q |
| 12/31/2022 | 02/02/2023 | 10-Q |
| 09/30/2022 | 11/01/2022 | 10-Q |
| 06/30/2022 | 08/10/2022 | 10-K |
| 03/31/2022 | 05/02/2022 | 10-Q |
| 12/31/2021 | 02/03/2022 | 10-Q |
| 09/30/2021 | 11/01/2021 | 10-Q |
| 06/30/2021 | 08/10/2021 | 10-K |
| 03/31/2021 | 04/30/2021 | 10-Q |
| 12/31/2020 | 02/04/2021 | 10-Q |
| 09/30/2020 | 11/02/2020 | 10-Q |
| 06/30/2020 | 08/13/2020 | 10-K |
| 03/31/2020 | 05/01/2020 | 10-Q |
| 12/31/2019 | 02/04/2020 | 10-Q |
| 09/30/2019 | 10/31/2019 | 10-Q |
| 06/30/2019 | 08/14/2019 | 10-K |
Recent Forward Guidance
Updated 7/9/2026Latest: Q3 2026 Earnings Reported 4/30/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Net Sales Growth | -6.0% | 2.0% | Raised | Guidance: -8.0% for 2026 | |||
| 2026 Organic Sales Growth | -9.0% | -2.0% | Lowered | Guidance: -7.0% for 2026 | |||
| 2026 Diluted EPS | 4.78 | 4.88 | 4.98 | -15.5% | Lowered | Guidance: 5.78 for 2026 | |
| 2026 Adjusted EPS | 5.45 | 5.55 | 5.65 | -9.4% | Lowered | Guidance: 6.12 for 2026 | |
Prior: Q2 2026 Earnings Reported 2/3/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Net Sales Growth | -10.0% | -8.0% | -6.0% | 0.0% | Affirmed | Guidance: -8.0% for 2026 | |
| 2026 Organic Sales Growth | -9.0% | -7.0% | -5.0% | 0.0% | Affirmed | Guidance: -7.0% for 2026 | |
| 2026 Diluted EPS | 5.6 | 5.78 | 5.95 | 0.0% | Affirmed | Guidance: 5.78 for 2026 | |
| 2026 Adjusted EPS | 5.95 | 6.12 | 6.3 | 0.0% | Affirmed | Guidance: 6.12 for 2026 | |
| 2026 Gross Margin Change | -1.0% | -0.75% | -0.5% | 0.0% | Affirmed | Guidance: -0.75% for 2026 | |
| 2026 Selling and administrative expenses | 0.16 | 0.0% | Affirmed | Guidance: 0.16 for 2026 | |||
| 2026 Advertising and sales promotion spending | 0.11 | 0.0% | Affirmed | Guidance: 0.11 for 2026 | |||
| 2026 Effective tax rate | 24.0% | 0.0% | Affirmed | Guidance: 24.0% for 2026 | |||
Q1 2026 Earnings Reported 11/3/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Net Sales Growth | -10.0% | -8.0% | -6.0% | 0 | Affirmed | Guidance: -8.0% for 2026 | |
| 2026 Organic Sales Growth | -9.0% | -7.0% | -5.0% | 0 | Affirmed | Guidance: -7.0% for 2026 | |
| 2026 Gross Margin Change | -1.0% | -0.75% | -0.5% | 0 | Affirmed | Guidance: -0.75% for 2026 | |
| 2026 Selling and Administrative Expenses | 0.16 | 0 | Affirmed | Guidance: 0.16 for 2026 | |||
| 2026 Advertising and Sales Promotion Spending | 0.11 | ||||||
| 2026 Effective Tax Rate | 24.0% | 0 | Affirmed | Guidance: 24.0% for 2026 | |||
| 2026 Diluted EPS | 5.6 | 5.78 | 5.95 | 0 | Affirmed | Guidance: 5.78 for 2026 | |
| 2026 Adjusted EPS | 5.95 | 6.12 | 6.3 | 0 | Affirmed | Guidance: 6.12 for 2026 | |
Insider Activity
Updated 5/5/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Breber, Pierre R | Trust | Buy | 5052026 | 85.82 | 5,000 | 429,124 | 1,544,846 | Form | |
| 2 | Breber, Pierre R | Trust | Buy | 11242025 | 104.13 | 4,000 | 416,516 | 1,353,678 | Form | |
| 3 | Reynolds, Eric H | EVP - Chief Operating Officer | Direct | Sell | 9082025 | 123.78 | 15,041 | 1,861,847 | 6,711,736 | Form |
| 4 | Breber, Pierre R | Direct | Buy | 5092025 | 136.57 | 4,000 | 546,285 | 546,285 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Breber, Pierre R | Trust | Buy | 5052026 | 85.82 | 5,000 | 429,124 | 1,544,846 | Form | |
| 2 | Breber, Pierre R | Trust | Buy | 11242025 | 104.13 | 4,000 | 416,516 | 1,353,678 | Form | |
| 3 | Reynolds, Eric H | EVP - Chief Operating Officer | Direct | Sell | 9082025 | 123.78 | 15,041 | 1,861,847 | 6,711,736 | Form |
| 4 | Breber, Pierre R | Direct | Buy | 5092025 | 136.57 | 4,000 | 546,285 | 546,285 | Form |
Investor Activity (13F)
Updated Jul 13, 2026Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank and community-bank filers are excluded.
| Active Manager | Value | % of Portfolio | Total Positions | QoQ | Filing |
|---|---|---|---|---|---|
| Minneapolis Portfolio Management Group, LLC | $38.8 Mil | 4.1% | 33 | New | 13F |
Industry Resources
| Consumer Staples Resources |
| FoodNavigator |
| Consumer Goods Technology (CGT) |
| Beverage Digest |
| Household Products Resources |
| Happi (Household and Personal Products Industry) |
| Nonwovens Industry |
| Consumer Reports - Household Products |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.